L

Lexicon Pharmaceuticals

D
LXRX
USD
-0.025
(-2.3148%)
Market Closed
53,448.00
حجم التداول
-0.85
الربح لكل سهم
-
العائد الربحي
-1.352564
P/E
381,374,371.23
حجم السوق
اليوم
-2.3148%
1 اسبوع
-17.899%
1 شهر
-41.226%
6 اشهر
-44.909%
12 اشهر
-4.955%
بداية السنة
-31.046%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Lexicon Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
هل تحتاج مساعدة او لديك استفسار؟